147 related articles for article (PubMed ID: 25340950)
1. 18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
Huang YT; Ravi Kumar AS; Bhuta S
Nucl Med Commun; 2015 Jan; 36(1):16-20. PubMed ID: 25340950
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging.
Dibble EH; Alvarez AC; Truong MT; Mercier G; Cook EF; Subramaniam RM
J Nucl Med; 2012 May; 53(5):709-15. PubMed ID: 22492732
[TBL] [Abstract][Full Text] [Related]
4. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
[TBL] [Abstract][Full Text] [Related]
5. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
[TBL] [Abstract][Full Text] [Related]
8. Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma.
Clark J; Jeffery CC; Zhang H; Cooper T; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):37. PubMed ID: 26374294
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
Tahari AK; Alluri KC; Quon H; Koch W; Wahl RL; Subramaniam RM
Clin Nucl Med; 2014 Mar; 39(3):225-31. PubMed ID: 24152652
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual homogeneity of
Sharma SJ; Wittekindt C; Knuth J; Steiner D; Wuerdemann N; Laur M; Kroll T; Wagner S; Klussmann JP
Oral Oncol; 2017 Oct; 73():166-171. PubMed ID: 28939071
[TBL] [Abstract][Full Text] [Related]
12. Relationship between extracapsular spread and FDG PET/CT in oropharyngeal squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
Acta Otolaryngol; 2013 Oct; 133(10):1073-9. PubMed ID: 24032571
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
[TBL] [Abstract][Full Text] [Related]
14. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Kendi AT; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Clin Nucl Med; 2015 Mar; 40(3):e196-200. PubMed ID: 25608156
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
[TBL] [Abstract][Full Text] [Related]
16. Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma.
Nesteruk M; Lang S; Veit-Haibach P; Studer G; Stieb S; Glatz S; Hemmatazad H; Ikenberg K; Huber G; Pruschy M; Guckenberger M; Klöck S; Riesterer O
Radiother Oncol; 2015 Oct; 117(1):125-31. PubMed ID: 26452710
[TBL] [Abstract][Full Text] [Related]
17. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
18. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
[TBL] [Abstract][Full Text] [Related]
20. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]